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Here we describe a 5-step sequence to prepare the AB enone 1, the key precursor to fully synthetic
tetracyclines, that begins with a diastereoselective Michael–Claisen coupling of two simple starting
materials, a cyclohexenone (compound 2 or, in a refinement, a substituted variant, vide infra) and the
isoxazole ester 3. This advance defines an 8-step linear sequence to 6-deoxytetracycline antibiotics from
three components of similar complexity (cyclohexenone 2, isoxazole ester 3, and structurally diverse
D-ring precursors) in which sequential diastereoselective Michael–Claisen cyclization reactions form
the A- and C-rings, respectively, of the linearly fused ABCD tetracycline skeleton. In addition to
providing a readily scalable, practical route to fully synthetic tetracyclines of broad structural diversity,
the sequence reported comprises a series of non-obvious stereoselective transformations, including
a novel means for C12a hydroxylation.
Introduction
Previously we showed that the AB enone 1 serves as a highly
versatile intermediate for the construction of diverse tetracycline
antibiotics.1,2 This key precursor can be transformed into fully
deprotected synthetic 6-deoxytetracyclines in a sequence of just 3
steps (illustrated by the synthesis of 6-deoxytetracycline, Scheme
1). A focal point in the production of novel tetracycline antibi-
otics in amounts necessary for drug discovery and manufacturing
efforts then has been the development of a practical and efficient
route to the AB enone 1. To date, we have reported two different
enantioselective routes to this substance. The first proceeded by
an 11-step linear sequence from benzoic acid as starting material
(10% yield) and provided gram-quantities of the crystalline AB
enone 1, but was challenging to scale in larger amounts.1 A
second, more convergent process proceeded in 5-steps (29%
yield) from the coupling of two precursors of similar complexity
[3-methoxyfurfural (4) and the isoxazole 5, Scheme 2] and has
proven to be more amenable to large-scale synthesis of 1.3
Detailed here is an entirely new strategy for the convergent
assembly of the AB enone 1, employing different coupling
components, derived by retrosynthetic disconnection of 1 at
positions distinct from those targeted in earlier approaches. The
route features a highly diastereoselective Michael–Claisen cycli-
zation reaction upon an existing B ring precursor, forming in one
step two carbon–carbon bonds and the A ring. Stereocontrolled
transformations of the (AB) cyclization product were then
developed, relaying the stereochemistry of position C4 (initially
non-homologous with natural tetracyclines, tetracycline
numbering) to position C12a, this by a later-stage hydroxylation
Scheme 1 Construction of ()-6-deoxytetracycline by Michael–Claisen
cyclization.1,2
Scheme 2 A second, more convergent synthesis of the AB enone 1.3
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reaction, and then back to C4, correcting the stereochemistry of
this position. The present process can be readily scaled and offers
many favorable features in this regard, such as the crystallinity of
intermediates at many stages of the process (allowing for puri-
fication without resort to chromatography) as well as an efficient
recycling protocol (vide infra).
Retrosynthetic analysis
In light of the efficiency and generality of the late-stage Michael–
Claisen cyclization reaction that was used to construct the C ring
of tetracyclines (Scheme 1), we were led to consider whether this
powerful transformation might also be applied to assemble the
AB enone 1 and specifically its A ring. Two obstacles prevented
direct application of a Michael–Claisen disconnection within
target 1. The first was the tert-butyldimethylsilyloxy group at
position C12a, which it seemed would have to be cleared to
provide a viable retron (Scheme 3), leading us to evaluate the
feasibility of C12a oxygenation by hydroxylation of a substrate
such as 6. That C12a hydroxylation might not proceed with
proper stereochemistry was an issue of initial concern, but one
that did not materialize in practice, where we observed that
a stereoisomer of compound 6 (the C4-epimer, structure 13,
Scheme 7, vide infra) was formed in the sequence we present
below. This proved fortuitous, for highly stereoselective
hydroxylation was achieved with this substrate, in the desired
sense. Second, beyond the issue of C12a hydroxylation was the
problem of identifying a suitable equivalent of 2,5-cyclo-
hexadien-1-one, which was clearly not a viable B-ring precursor
in light of its propensity to aromatize (Scheme 3).4 Contributions
from the Ogasawara–Takano laboratories over many years have
defined a practical and versatile equivalent of 2,5-cyclohexadien-
1-one in the form of its cyclopentadiene-Diels–Alder adduct 2.
Through their research this compound is now readily available in
both enantiomeric forms.5–7 Ogasawara, Takano, and co-
workers, as well as other research groups, have shown that the
versatile building block 2 can be transformed into an extraordi-
nary variety of structures in just a few steps, one of these being an
obligate high-temperature retro-Diels–Alder reaction that expels
cyclopentadiene.8
By the analysis above, the specific transformation we were led
to explore initially was the Michael–Claisen condensation
reaction of the Ogasawara–Takano cyclohexenone 2 and methyl
3-benzyloxy-5-(dimethylaminomethyl)isoxazole-4-carboxylate
(3). We refer to the latter compound as the Stork–Hagedorn
isoxazole, recognizing the first reported use of the 3-benzyloxy-
isoxazole function as a protective group for the A-ring of tetra-
cyclines, an innovation critical to our own work.9 The Stork
laboratory subsequently described a remarkably efficient
synthesis of C12a-deoxytetracycline from this same starting
material using stepwiseMichael and Claisen cyclization reactions
to form the A-ring, with a different sequencing than that
reported here.10 In the present application, neither the feasibility
nor the likely stereochemical outcome of the proposed single-step
condensation (2 + 3) were known at the outset of our work. In
the following section, we detail a practical and short sequence for
the synthesis of the AB enone 1. We also describe further inno-
vations in the route, including the development of a modified
Ogasawara–Takano enone (containing an 11-dimethylphe-
nylsilyl substituent, structure 25, Scheme 9, vide infra), which has
permitted large-scale synthesis of 1 in pure form without
resorting to column chromatography.
Results and discussion
The Ogasawara–Takano cyclohexenone 2 was synthesized in
three steps by simple modifications of procedures originally
reported for the preparation of this substance (Scheme 4).5 Thus,
reduction of the cyclopentadiene-benzoquinone Diels–Alder
adduct 711with sodium borohydride (1.2 equiv) in the presence of
cerium chloride (2 equiv) in methanol provided themeso diol 8 in
97% yield.12,13 Enantioselective acylation of 8 was best accom-
plished using an immobilized Amano lipase (Pseudomonas sp.)
and isopropenyl acetate (3 equiv) as the acetylating agent in
triethylamine as solvent. The use of triethylamine alone as the
solvent and isopropenyl acetate as the acetylating agent represent
departures from the original protocols.5,7 By using the combi-
nation of lipase, acetylating agent, and solvent specified we
observed complete transformation of 8 within 22 h, and obtained
the monoacetate 9 free of any bis-acylated material, a by-product
we observed to form in small amounts (1–5% yield) when vinyl
acetate was used as the acetylating agent.5,7 The immobilized
lipase could be recovered by filtration of the product mixture
Scheme 3 A Michael–Claisen cyclization approach to A-ring
construction. Scheme 4 Synthesis of cyclohexenone 2.
This journal is ª The Royal Society of Chemistry 2011 Chem. Sci., 2011, 2, 1710–1718 | 1711
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through a sintered-glass funnel, rinsing the filter cake with ethyl
acetate, and then drying the rinsed lipase in vacuo (0.1 mmHg) at
23 C. The recovered, dried lipase could be recycled over at least
two iterations without diminution in the yield or enantiose-
lectivity of the monoacetate product (9). As reported by Oga-
sawara and Takano, exposure of monoacetate 9 to dichlorobis
(triphenylphosphine)palladium(II) (1 mol %) in the presence of
ammonium formate (1.25 equiv) in refluxing acetonitrile affor-
ded the cyclohexenone 2 in 79% yield after purification by
chromatography on silica gel (>99% ee, chiral GC analysis).5,14
This practical 3-step sequence to the cyclohexenone 2 did require
final purification by column chromatography in order to achieve
optimal results in subsequent transformations, a purification step
not practiced when using a silyl-substituted variant of cyclo-
hexenone 2, discussed below. The cyclohexenone 2 was liquid at
23 C and solidified at 20 C. Typically, 30–35-g batches of
cyclohexenone 2 were prepared.
The Stork-Hagedorn isoxazole (3)9,10 was readily prepared in
large amounts by the sequence outlined in Scheme 5, beginning
with the known substance methyl 3-hydroxyisoxazole-5-
carboxylate (10) (see Supporting Information for details†).15,16
To form the A-ring of the AB enone 1, the isoxazole ester 3
(130 g, 1.05 equiv) was deprotonated with sodium hexame-
thyldisilazide (1.05 equiv) in tetrahydrofuran (78 C for 20 min,
20 C for 1 h, then re-cooling to 78 C). The resulting thick
slurry was stirred mechanically at 78 C while a solution of the
cyclohexenone 2 (68.0 g, 1 equiv) was added over the course of 45
min, leading to formation of the Michael addition product (thin-
layer chromatographic analysis, not characterized, Scheme 6).
After 30 min, a solution of potassium hexamethyldisilazide (1.05
equiv) in toluene was added over 70 min so as to ensure that the
Claisen product was deprotonated rapidly as it was formed
during the subsequent warming step. Failing this, the cyclization
reaction was observed not to proceed to completion, presumably
due to quenching of the enolate intermediate (11) by proton
transfer from the 1,3-diketone product or methanol. Claisen
cyclization proceeded upon warming to 20 C and was
complete within 6 h. After an aqueous workup and purification
by flash column chromatography on silica gel the Michael–
Claisen cyclization product 12 was obtained as a pale yellow
foam (143 g, 80%). 1H NMR analysis (CDCl3) revealed that the
product was entirely enolic and, within the limits of detection,
a single diastereomer.17
Analysis of proton–proton coupling constants strongly sup-
ported the stereochemical assignments depicted in structure 12;
these were confirmed by later transformations and, ultimately,
X-ray crystallographic analysis (vide infra). Interestingly, when
we evaluated the condensation of the cyclohexenone 2 with the
corresponding enolate derived from the isoxazole phenyl ester as
the nucleophile (in lieu of the enolate derived from the methyl
ester) under conditions otherwise identical to those described
above, the rates of the Michael and Claisen reactions were
observed to be similar, and the yield of the Michael–Claisen
cyclization product was lower (44%), presumably a consequence
of competing proton transfer. We believe that the higher yield of
the Michael–Claisen condensation of the enolate derived from
the methyl ester 3 with (essentially an equimolar amount of) the
cyclohexenone coupling component 2 is in large measure due to
the fact that the Claisen cyclization reaction is rate determining
with these substrates.
Michael addition proceeds by addition of the sodium enolate
to the sterically more accessible face of cyclohexenone 2 as
expected based on precedent8 and, strikingly, with complete
control of the relative stereochemistry of the C4 and C4a centers.
This provides an additional instance of high diastereocontrol in
the creation of adjacent stereogenic sp3-centers by Michael–
Claisen cycloaddition (another being the formation of the
C-ring, exemplified in Scheme 1), suggesting that this powerful
ring-forming reaction may be more broadly applicable as
a method for the stereocontrolled construction of 6-membered
rings. Interestingly, comparison of the cycloaddition reactions of
Scheme 1 and Scheme 6 reveals that they are non-homologous
stereochemically, if the methyl and dimethylamino substituents
of the respective enolate intermediates are given equal prioriti-
zation. In both cases nucleophilic addition to the b-position of
each cyclohexenone is believed to occur along a pseudoaxial
trajectory, but this pathway is believed to be sterically much
more restricted in the case of the AB enone 1 relative to the
cyclohexenone 2 (the C4 position of enone 1 presents a pseudo
1,3-diaxial interaction during Michael addition). The tert-
butyldimethylsilyloxy substituent at position C12a is believed to
block nucleophilic addition to the a-face of enone 1, much as theScheme 5 Synthesis of isoxazole ester 3.
Scheme 6 Michael–Claisen cyclization reaction of components 2 and 3.
1712 | Chem. Sci., 2011, 2, 1710–1718 This journal is ª The Royal Society of Chemistry 2011
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cyclopentadienyl residue blocks addition to the a-face of cyclo-
hexenone 2.8 The enolates are of course also quite different,
having different counterions, as well as substituents with
potentially quite different propensities for metal (counterion)
binding, and this, too, may play a role in the differing stereo-
chemical outcomes of A- and C-ring formation.
Although the stereochemistry of position C4 within the
Michael–Claisen cyclization product 12 did not correspond with
that of naturally occurring tetracyclines, we imagined that this
product might serve as a viable precursor to the AB enone 1
nevertheless, provided that epimerization at position C4 could be
achieved subsequently. The most viable sequence appeared to be:
(1) expulsion of cyclopentadiene from 12 by retro-Diels–Alder
reaction [hydroxylation of 12 (or its C4 epimer), if it could be
achieved at all, would almost certainly not proceed with correct
stereochemistry at C12a due to steric blocking by the cyclo-
pentenyl group] (2) hydroxylation of the retro-Diels–Alder
product 13, and (3) C4-epimerization. As discussed in the
introduction, having obtained the ‘‘incorrect’’ stereochemistry at
position C4 during the Michael–Claisen cycloaddition reaction
was likely advantageous, as it was unclear that C12a-hydroxyl-
ation could have been achieved in the desired sense at any stage
had C4 been set with the ‘‘correct’’ stereochemistry.
In accord with literature precedent,18 retro-Diels–Alder frag-
mentation of the Michael–Claisen cyclization product 12 pro-
ceeded rapidly only at temperatures above 200 C. As
a complication, the cyclohexenone produced (13, Scheme 7) was
observed to undergo partial decomposition under the conditions
of thermolysis and this appeared to be exacerbated at higher
concentrations of substrate (12).19 The optimized protocol for
thermolysis then involved a short contact time at elevated
temperature and a relatively dilute substrate solution.
Specifically, a solution of substrate 12 (143 g, 0.02 M) and
dimethyl maleate (213 mL, 5 equiv, added as a trapping agent for
cyclopentadiene) in diphenyl ether (14 L) was pumped continu-
ously using a peristaltic pump through a stainless-steel tube
submerged in an oil bath heated to 250 C at a flow rate of
12 mL min1 (Scheme 7, for details of the apparatus, including
photographs, see Supporting Information†). Addition of
hydrogen chloride to the cooled product solution led to precip-
itation of the product as its hydrochloride salt. This was
collected, the corresponding free base was formed, and the latter
(13) was purified by a combination of crystallization (31.0 g,
yellow prisms, mp 103–105 C, 1st crop) and flash column
chromatography (36.0 g, yellow solid, mp 103–105 C, 2nd crop).
The total yield of pure retro-Diels–Alder product 13 was 55%
(67.0 g). The crystals collected in the 1st crop were suitable for
X-ray analysis. The solid-state structure we obtained, depicted in
Fig. 1, provided confirmation of stereochemistry and a basis for
optimism that C12a-hydroxylation of 13 (or more properly an
anion derived from it) might proceed by selective attack of the
oxidant on the a-face, for the b-face appeared to be largely
blocked by the C4-dimethylamino group. The high-temperature,
continuous-flow retro-Diels–Alder reaction we developed was
not easily reproduced without meticulous attention to detail in
setup of the specialized reaction apparatus and this, coupled with
the large volume of high-boiling solvent required, compelled us
to develop an alternative protocol (vide infra), but first we sought
to establish that intermediate 13 could serve as a precursor to the
AB enone 1.
An extensive literature describes with somewhat mixed success
late-stage C12a-hydroxylation reactions in tetracycline synthesis,
including each of the formative studies in the field. In the first
fully synthetic route to any tetracycline antibiotic, (d,l-6-
demethyl-6-deoxytetracycline, sancycline, 17), Woodward and
co-workers reported that d,l-6-demethyl-6,12-dideoxytetracy-
cline (16) was hydroxylated in the presence of dioxygen and
cerous chloride in buffered methanol-DMF to provide synthetic
sancycline in 6.5% yield (Scheme 8).20 In their synthesis of
d,l-terramycin, the Muxfeldt laboratory described a more effi-
cient C12a-hydroxylation reaction (18 / 19, 52% yield) using
a different protocol, also employing dioxygen as the stoichio-
metric oxidant.21 A later publication from the Stork laboratories
reported that conditions could not be found to achieve late-stage
C12a hydroxylation of 12a-deoxytetracycline to produce tetra-
cycline itself (20 / 21).10 We recognized that C12a-hydroxyl-
ation of the retro-Diels–Alder product 13 is different
contextually than the examples in the references cited, for the
vinylogous carbamic acid group of the tetracyclines is masked in
the form of the Stork-Hagedorn isoxazole residue9 and, of
course, the substrate we imagined for hydroxylation (13) lacks
Scheme 7 Synthesis of AB enone 1. Fig. 1 X-ray crystal structure of the retro-Diels–Alder product 13.
This journal is ª The Royal Society of Chemistry 2011 Chem. Sci., 2011, 2, 1710–1718 | 1713
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the extended conjugation within the C- and D-rings that is
characteristic of the substrates in Scheme 8.
In the present case, stereoselective C12a hydroxylation of
substrate 13 was best achieved using as stoichiometric oxidant
a reagent other than dioxygen. In the protocol we first employed
for large-scale hydroxylation of 13 (a modified procedure is
presented below) the Davis sulfonyloxaziridine22 (60.5 g, 1.32
equiv) was added portion-wise as a slurry in 1,2-dimethoxy-
ethane (DME) over 1 h to a mechanically stirred, cold (30 C)
slurry of an enolate obtained by deprotonation of 13 (67.0 g, 1
equiv) in the presence of anhydrous lithium chloride (1.1 equiv)
in DME at 30 C using as base a freshly prepared solution of
lithium hexamethyldisilazide (1.1 equiv) in DME. After an
aqueous workup involving extraction of the product into water
as its hydrochloride salt, then formation of the corresponding
free base, concentration afforded the C12a-hydroxylation
product 14 as a purple foam, estimated by 1H NMR analysis to
be >95% a single diastereoisomer (48.0 g, 68% crude yield, an
accurate yield is reported after the subsequent steps, C4-epime-
rization and hydroxyl protection).
It has long been known that position C4 of tetracyclines is
subject to epimerization under various conditions. Scientists at
Lederle laboratories reported in 1955 that tetracycline undergoes
equilibration in 1 M aqueous sodium dihydrogen phosphate-
methanol (2 : 1, 25 C, 24 h) to afford a 1.5 : 1 mixture of natural
(4S) and nonnatural (4R) stereoisomers, respectively.23 Nose-
worthy,24 and later Woodward in collaboration with Pfizer
scientists, showed that under somewhat different conditions
(CaCl2, water-butanol containing ethanolamine, pH 8.5, reflux,
3.5 h) a mixture of C4-epimers of sancycline is isomerized to
afford predominately the natural (4S)-stereoisomer.20 These
examples are somewhat distantly removed from the substrate of
present interest, the (4R)-C12a hydroxylation product 14. In the
event, when a solution of the latter was heated at 52 C for 15 h in
a mixed solvent containing tetrahydrofuran (2 parts), methanol
(2 parts), and 2 M aqueous sodium dihydrogen phosphate
solution (3 parts) almost complete isomerization to the desired
4S-epimeric product (15) occurred. The ratio of desired to
undesired epimers was 11.1 to 1. The diastereomers could be
separated by column chromatography; resubjection of the pure
desired (4S)-isomer to the conditions of epimerization gave rise
to the same 11.1 : 1 ratio of epimers obtained from the (4R)-
isomer, which establishes that this is the equilibrium ratio under
the conditions defined (later, we show that the equilibrium ratio
is improved under slightly modified conditions). In practice, the
diastereomeric mixture was not separated. Rather, the mixture
was silylated directly (TBSOTf, 2,6-lutidine, CH2Cl2, 0
C) to
provide the AB enone 1. The undesired (4R)-epimer 14 does not
undergo silylation under these reaction conditions and is easily
separated from the AB enone 1. The three steps (13/ 14/ 15
/ 1) were conducted in sequence with final chromatographic
purification on silica gel; the yield for the three steps was 42%. In
the largest single-batch implementation of the 5-step sequence
outlined (beginning with the coupling of the cyclohexenone 2 and
the isoxazole ester 3) we prepared 39.1 g of the AB enone 1 in
18% yield overall. Three chromatographic purification steps were
necessary.
For the reasons outlined above we sought to modify the 5-step
sequence in order to avoid the high-temperature retro-Diels–
Alder reaction. A number of different strategies have been
described to modify the diene-derived component of norbornenyl
Diels–Alder adducts so as to facilitate their thermal fragmenta-
tion.18 Modified dienes include 1,1-dimethylfulvene in the early
research of Alder and co-workers25 and later by Ichihara and co-
workers,26 5-trimethylsilylcyclopentadiene in the research of
Magnus and co-workers and applied by them in the synthesis of
aspidosperma alkaloids,27 pentamethylcyclopentadiene in the
research of Grieco and co-workers and applied by them in
the synthesis prostaglandins,28 and spiro[2.4]hepta-4,6-diene in
the research of Kotha and Sunoj.29 Of these, the use of 5-trime-
thylsilylcyclopentadiene reported by Magnus and co-workers27
was particularly appealing because of its simplicity and the
possibility that the 5-silylcyclopentadiene might be recycled
(5-trimethylsilylcyclopentadiene is known to be greatly favored
over the 1- and 2-trimethylsilylcyclopentadiene isomers at
equilibrium).30
In the present work both 5-trimethylsilylcyclopentadiene and
5-dimethylphenylsilylcyclopentadiene were examined as
substrates. We observed that intermediates containing the
dimethylphenylsilyl substituent had a greater propensity to be
crystalline, and so our focus turned to this specific substitution.
5-Dimethylphenylsilylcyclopentadiene (22a) was prepared using
the protocol of Landais and Parra-Rapado for guidance.31
Lithium cyclopentadienide, formed from freshly cracked cyclo-
pentadiene (58.1 g, 1 equiv) and n-butyllithium (1 equiv), was
trapped at 78 C with dimethylphenylchlorosilane (150 g, 1
equiv) to provide (after an aqueous workup that involved only
brief warming to 23 C) in quantitative yield (175 g) a kinetic
distribution of dimethylphenylsilylcyclopentadienes that con-
tained approximately 92% of the 5-dimethylphenylsilylcyclo-
pentadiene (22a) isomer (Scheme 9). The mixture of dienes was
liquid at 23 C and solid at80 C. The diene mixture was stored
at 80 C to prevent isomerization.
Combination of the diene mixture (124 g, 92% 22a, 539 mmol
22a, 1 equiv 22a) and benzoquinone (63.3 g, 1.03 equiv) in a 2 : 1
Scheme 8 Late-stage C12a-hydroxylation reactions in tetracycline
synthesis.20,21,10
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mixture of methanol and dichloromethane at 0 C led to
complete cycloaddition within 12 h to form the expected
11-dimethylphenylsilyl endo enedione adduct (not depicted). The
product was not isolated at this stage; rather, cerium trichloride
heptahydrate (109 g, 0.51 equiv) and sodium borohydride (22.2
g, 1.03 equiv) were added in sequence, affording themeso diol 23,
which was readily isolated in pure form by recrystallization from
dichloromethane–hexanes (129 g, 67% yield from the total mass
of 124 g, 73% yield based on the amount of 22a present, mp
98–100 C). Enzymatic desymmetrization of the meso diol 23
(150 g) was achieved using the same immobilized lipase as above
(Amano, Pseudomonas sp., 150 g) and isopropenyl acetate (3.5
equiv) as the acetylating agent in triethylamine as solvent to form
monoacetate 24, which was isolated as a white solid (159 g, 95%
yield, mp 68–72 C) after decolorization with charcoal (Darco
G-60).
Palladium-catalyzed rearrangement of the monoacetate
product (24) was optimally conducted by substantial modifica-
tion of the protocol of Ogasawara and Takano.5,14 In exploratory
experiments, where we evaluated the suitability of the conditions
originally developed by Ogasawara and Takano to transform the
monoacetate 9 to the cyclohexenone 2 (Scheme 4 above) for the
parallel transformation of the dimethylphenylsilyl-substituted
monoacetate 24 to the cyclohexenone 25, we observed that
phenol was formed as a substantial by-product and this appeared
to be accelerated at elevated reaction temperatures (>30 C).
Presumably, this arose by a formal retro-Diels–Alder fragmen-
tation of the cyclohexenone 25, although step-wise mechanisms
(including palladium-mediated processes) can also be envisioned
to transform 25 to phenol. By substantial modification of the
catalyst and solvent we were able to effectively suppress the
formation of phenol. Specifically, the use of [1,10-bis(diphenyl-
phosphino)ferrocene]dichloropalladium(II) (4 mol%) as catalyst
in a 12 : 1 solvent mixture of dimethylformamide and water at 23
C led to complete and clean transformation to the cyclo-
hexenone 25 within 16 h. The reaction mixture was diluted with
a 1 : 1 mixture of methyl tert-butyl ether and water and the
resulting biphasic solution was stirred with charcoal (Darco
G-60) at 10 C for 1 h. The whole mixture was filtered through
a pad of Celite, the filtrate was subjected to an aqueous workup,
and the organic layer was concentrated, affording a brown solid.
The cyclohexenone 25 was observed to decompose upon expo-
sure to silica gel or basic alumina; in both cases phenol was
formed.32 In lieu of purification by column chromatography, the
crude solid product was dissolved in methyl tert-butyl ether and
the resulting solution was stirred over a resin containing 2,4,6-
trimercaptotriazine immobilized on a polystyrene solid support
(MP-TMT, Biotage) at 23 C for 16 h. Filtration through a sin-
tered-glass funnel and then concentration of the filtrate afforded
the cyclohexenone 25 as an orange solid (124 g, 82% crude yield,
est. >90% purity by 1H NMR analysis).
An adaptation of the protocol developed for the Michael–
Claisen cyclization of cyclohexenone 2 and isoxazole ester 3
(Scheme 6 above) was applied for the coupling of dimethylphe-
nylsilyl-substituted cyclohexenone 25 and isoxazole ester 3.
Thus, a solution of cyclohexenone 25 (124 g, 1 equiv) in tetra-
hydrofuran was added over the course of 40 min to a mechan-
ically stirred slurry of the sodium enolate derived from the
isoxazole ester 3 (134 g, 1.1 equiv) obtained in this case by
deprotonation with sodium hexamethyldisilazide (1.15 equiv) in
tetrahydrofuran at 50 C. Formation of the Michael adduct
appeared to be complete within 1 h at 50 C (based on TLC
analysis, not characterized), and, as before, potassium hexame-
thyldisilazide (1 equiv) was added to ensure that the Claisen
product was deprotonated rapidly as it was formed. Claisen
cyclization in the present transformation was initiated by
warming to 20 C over the course of 1 h and proceeded to
completion within 2 h at 20 C; the reaction solution was
additionally held for 2 h at 10 C. After an aqueous workup,
addition of hydrogen chloride led to formation of a hydrochlo-
ride salt, which was recrystallized from dichloromethane–ethyl
acetate (off-white solid, mp 158–160 C). X-ray crystallographic
analysis established that this intermediate was stereochemically
homologous with the non-silylated intermediate 12 above
(Fig. 2). The cycloadduct 26 was isolated as a white foam upon
formation of its free base (146 g, 62% yield overall).
In our preferred sequence for retro-Diels–Alder reaction, the
Michael–Claisen cyclization product 26 (85.0 g) was heated in
toluene at reflux for 10 h (Scheme 10), producing an equilibrium
distribution of dimethylphenylsilylcyclopentadiene isomers
Scheme 9 Introduction of the dimethylphenylsilyl group.
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(detailed below) and the desired retro-Diels–Alder product (13).
The latter was obtained as yellow prisms by concentration of the
reaction mixture and crystallization of the residue from ethyl
acetate–hexanes (38.0 g, mp 103–105 C, 1st crop). The isomeric
dimethylphenylsilylcyclopentadienes were readily isolated by
filtration of the mother liquors through a pad of silica gel, eluting
with hexanes. Additional retro-Diels–Alder product 13 was
obtained by further elution of the silica pad with ethyl acetate–
hexanes, concentration of the eluent, and recrystallization of the
solid product from ethyl acetate–hexanes to afford a second crop
of crystals (9.40 g, mp 103–105 C). The total amount of crys-
talline retro-Diels–Alder product 13 obtained was 47.4 g
(87% yield).
Concentration of the hexanes eluent containing the isomeric
dimethylphenylsilylcyclopentadienes afforded 92% (28.5 g) of the
theoretical mass, comprised of the following isomeric distribu-
tion (1H NMR analysis): 22a (75%), 22b (18%), 22c (7%). It was
possible to separate the 5-dimethylphenylsilylcyclopentadiene
isomer (22a) from the isomeric pair 22b and 22c by careful
column chromatography. We separately subjected the samples
enriched in the 5-dimethylphenylsilylcyclopentadiene isomer
(22a) and the mixture of isomers 22b and 22c to conditions of
reflux in toluene (10 h, bath temperature 120 C) and in each case
obtained the identical distribution of isomers (within experi-
mental error) listed above, which therefore must represent
the equilibrium distribution at 120 C (see Supporting
Information†). This is clearly advantageous in the present
context, for it allows for recycling of the preponderance of the
dimethylphenylsilylcyclopentadienyl retro-Diels–Alder product.
In practice, combination of the unpurified dimethylphenylsi-
lylcyclopentadiene mixture as obtained (28.5 g, 75% 22a,
107 mmol 22a, 1 equiv 22a) with benzoquinone (1.26 equiv) in
methanol-dichloromethane at 0 C formed the 11-dimethylphe-
nylsilyl endo enedione adduct (not shown); the latter was reduced
in situ (CeCl3$7H2O, NaBH4) to afford meso diol 23 as a white
solid after purification by recrystallization from dichloro-
methane–hexanes (22.4 g, 50% yield from the total diene mass
of 28.5 g, 67% yield from the amount of 22a present, mp
98–100 C).
Two other conditions for retro-Diels–Alder fragmentation of
the Michael–Claisen cyclization product 26 were also identified.
Brief heating of 26 in diphenyl ether at 170 C for 6 min provided
the retro-Diels–Alder product 13 in 93% yield (Scheme 11). Also,
heating 26, in the form of its hydrochloride salt, in hexa-
fluoroisopropanol (HFIPA) at reflux for 12 h afforded the
retro-Diels–Alder product 13 in 69% yield. Recovery of the silyl-
substituted diene was not possible in the latter transformation,
perhaps because protodesilylation occurred, though this specu-
lation is not yet supported by experimental evidence.
With an improved sequence to the retro-Diels–Alder product
13 we had further opportunity to optimize the final three steps
that transform this intermediate into AB enone 1 (Scheme 12). In
the C12a-hydroxylation reaction, 3-(4-nitrophenyl)-2-(phenyl-
sulfonyl)-oxaziridine was chosen as the stoichiometric oxidant in
place of the original Davis oxaziridine in view of the reported
greater thermal stability of the former33 and lithium tert-butoxide
was used as base, in amounts as little as 20 mol%, in place of
stoichiometric lithium hexamethyldisilazide as base. These
adjustments to the protocol for C12a-hydroxylation led to an
increased yield of product (14, 42.5 g, 85%, not purified). Our
optimized protocol for epimerization employed a more concen-
trated aqueous solution of sodium dihydrogen phosphate and
a higher reaction temperature; the ratio of the desired (4S)-
epimer to the undesired (4R)-epimer increased to 12.8 to 1 with
these modifications. Silylation of 15 proceeded as before
(TBSOTf, 2,6-lutidine, CH2Cl2, 0
C) with slight modifications in
Fig. 2 X-ray crystal structure of the hydrochloride salt of 26.
Scheme 10 Retro-Diels–Alder reaction with dimethylphenylsilyl
substitution. Scheme 11 Alternative retro-Diels–Alder reaction conditions.
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the workup which allowed for purification without resort to
column chromatography. Thus, after silylation was complete,
anhydrous methanol (9 mL) was added to quench any excess tert-
butyldimethylsilyl trifluoromethanesulfonate; the volatile by-
product, methyl tert-butyldimethylsilyl ether, was removed upon
rotary evaporation. In addition, we found that 2,6-lutidine could
be extracted selectively into pH 5 (0.1 M) aqueous sodium citrate
buffer. After partial decolorization with charcoal, the AB enone
1 was obtained as an orange solid. Recrystallization from ethyl
acetate provided a 1st crop of pure AB enone 1 as a white solid
(31.6 g, mp 148–150 C). Two additional crops of pure AB enone
1 were obtained upon further recrystallization from ethyl
acetate–heptanes (2nd crop: 6.00 g, mp 148–150 C; 3rd crop:
4.00 g, mp 149–151 C). The optical rotation of the AB enone 1
([a]24D + 148, c 1.13, CHCl3) confirmed that the product was of
high optical purity.34 In the largest single-batch implementation
of the optimized 5-step sequence outlined (beginning with the
coupling of the cyclohexenone 25 and the isoxazole ester 3) we
prepared 41.6 g of pure AB enone 1 in 35% yield overall. There
were no chromatographic purification steps.
Conclusions
The third- and fourth-generation routes to the AB enone 1 pre-
sented herein (employing cyclohexenones 2 or 25, respectively,
and the isoxazole ester 3 as starting materials), like the second-
generation route that preceded them, comprise 5-step synthetic
sequences from a point of convergence that features the coupling
of two simple starting materials, both readily prepared in large
amounts. In the current work the two coupling components are
of nearly equal complexity, as measured by the number of steps
required to prepare each starting material. Asymmetry is intro-
duced with the B-ring precursor and transferred via a highly
diastereoselective Michael–Claisen cyclization to positions C4
and C4a and from these to position C12a by late-stage hydroxy-
lation. In contrast, asymmetry is introduced in the second-
generation route within the isoxazole precursor, at position C4,
and this was relayed to positions C4a and C12a in
a diastereoselective Diels–Alder cycloaddition reaction.3 The
5-step sequences of the second- and fourth-generation routes
readily provide 40–50-g batches of crystalline AB enone 1 in
comparable overall yields, using non-specialized laboratory
apparatus. The fourth-generation route offers the advantage of
many crystalline or solid intermediates, which permits synthesis
of 1 without resort to chromatography (although a silica pad is
employed in a recycling step). For kilogram-scale synthesis of
fully synthetic tetracyclines, the fourth-generation route we
present would require additional experimentation using appro-
priate and safe reaction vessels, however we believe that the
current study provides a strong foundation for such research. Of
greater importance in our ongoing efforts to discover new classes
of tetracycline antibiotics is the fact that the fourth-generation
route is more amenable to component modification for the
preparation of structural variants of the AB enone 1, allowing
modification of the tetracycline structure at positions such as C4,
C4a, C5, and C12a, which heretofore have been relatively little
explored because such compounds were largely inaccessible.
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